Skip to main navigation Skip to search Skip to main content

Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility

Research output: Contribution to journal › Comment/debate › peer-review

Original languageEnglish (US)
Pages (from-to)1717-1718
Number of pages2
JournalJAMA - Journal of the American Medical Association
Volume325
Issue number17
DOIs
StatePublished - May 4 2021

ASJC Scopus subject areas

  • General Medicine

Cite this